display:none
Skip to main content

Comparison Chart for the U.S. Regulatory Pathways

About this resource

Regulations, Digital Health Products
Download Comparison Chart for the U.S. Regulatory Pathways

Related resources that might interest you

Advancing a Sustainable Hospital-at-Home Ecosystem at Scale

Tool

Removing harmful race-based clinical algorithms: A toolkit

Tool

Simulator of study power for Parkinson’s Disease trials

Tool, Case Study

Digital Endpoints Business Case Template

Tool, Case Study

Value of novel digital endpoints in late-stage trials

Tool, Case Study

Advancing digital biomarkers to accelerate Parkinson’s disease drug development

Tool, Case Study

Multimodal digital health technologies (DHTs) allow for more efficient and less costly recruitment and reduced patient burden with decentralized clinical trials

Tool, Case Study

Digital Endpoints ROI Calculator

Tool, Case Study

Enhancing clinical insights: De-risking traditional outcome measures in Bellerophon Therapeutics REBUILD study

Tool, Case Study

Digital Endpoints Value Framework

Tool, Case Study

Estimating the benefits of digital and plasma-based pre-screening in Alzheimer’s Disease trial recruitment

Tool, Case Study

Multimodal digital measures demonstrate greater responsiveness and sensitivity to disease progression and treatment effects than traditional clinical scales

Tool, Case Study

Driving innovation in Huntington’s Disease by tracking progression through at-home digital measurements

Tool, Case Study

Advancing nano-rare disease treatment with Syde technology in clinical trials

Tool, Case Study

Accelerated trial setup & operations: A case study in Cystic Fibrosis to illustrate the ROI of improved data availability

Tool, Case Study

High-Quality Evidence for DHTs — A Checklist

Template

DiMe Case Study: Caption Health – Stage C

Case Study

DiMe Case Study: Caption Health – Stage B

Case Study

DiMe Case Study: Caption Health – Stage A

Case Study

DiMe Case Study: Applied VR – Stage C

Case Study